Skip to main content
Premium Trial:

Request an Annual Quote

Quest, Clinical Genomics Extend Deal for Colorectal Cancer Biomarkers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian biotech firm Clinical Genomics today announced the extension of a deal with Quest Diagnostics covering Clinical Genomics' biomarkers for colorectal cancer and precancerous colorectal cancer tumors.

Under the terms of the extension, Quest will make unspecified milestone payments to Clinical Genomics to develop and validate molecular tests for the early detection of the cancer. In 2009, the firms announced a licensing deal to develop Clinical Genomics' biomarkers as a detection tool.

As part of the original agreement, Quest has made payments to Clinical Genomics after it achieved key research and development goals.

Citing statistics from the American Cancer Society, Clinical Genomics said that colorectal cancer is the second most common cause of cancer death in the United States. Among the tests offered by Quest for the detection of the disease are ColoVantage and InSure.

"By extending our alliance with Quest Diagnostics, we will continue to transition Clinical Genomics' research of colorectal cancer gene targets into clinical testing services for the large underserved market of the Unites States and other countries," Clinical Genomics CEO Lawrence LaPointe said in a statement.

The Scan

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.

Analysis of Endogenous Parvoviral Elements Found Within Animal Genomes

Researchers at PLOS Biology have examined the coevolution of endogenous parvoviral elements and animal genomes to gain insight into using the viruses as gene therapy vectors.

Saliva Testing Can Reveal Mosaic CNVs Important in Intellectual Disability

An Australian team has compared the yield of chromosomal microarray testing of both blood and saliva samples for syndromic intellectual disability in the European Journal of Human Genetics.

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.